Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: If we lose Acer/Barco/HTC

I would appreciate your thoughts on what might happen should it be determined that Barco/Acer/HTC do not infringe on the MMP portfolio. Will that in effect mean that the true value of the portfolio will be diminished to the point where the following provision of the ComAg could be effected. Should we prevail, would that in and of itself mean that there has been no material reduction in the commercial value of the patents?

5.2 In the event that facts or events are discovered or occur which

materially reduce TPL's evaluation of the useful life or commercial value of the

MSD Patents, or the viability of the Project, TPL may reduce the term of this

Commercialization Agreement accordingly by providing P-Newco with ninety (90)

days written notice, provided that TPL shall not reduce the term of this

Commercialization Agreement to less than six (6) months.

Share
New Message
Please login to post a reply